Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
-696K
-
Total reported value, excl. options
-
$13.7B
-
Value change
-
-$203M
-
Put/Call ratio
-
3.3
-
Number of buys
-
118
-
Number of sells
-
-129
-
Price
-
$258.39
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2020
293 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q4 2020.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
of 1.39B outstanding shares and own 3.84% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.7M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (5.47M shares), Capital International Investors (5.37M shares), FMR LLC (4.7M shares), BAILLIE GIFFORD & CO (4.25M shares), PRIMECAP MANAGEMENT CO/CA/ (3.37M shares), Temasek Holdings (Private) Ltd (2.65M shares), BlackRock Inc. (2.59M shares), WELLINGTON MANAGEMENT GROUP LLP (1.44M shares), and BOXER CAPITAL, LLC (1.11M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.